论文部分内容阅读
目的分析血栓通治疗脑出血的临床疗效。方法 87例脑出血患者随机分为对照组(43例)及治疗组(44例);对照组给予常规治疗,治疗组在常规治疗基础上加用血栓通注射液,对比两组患者临床效果。结果治疗组患者脑血肿体积为(3.27±2.33)ml,总体变化优于对照组(5.39±2.13)ml,两组比较差异有统计学意义(P<0.05);治疗组总有效率为88.6%优于对照组65.1%,两组比较差异有统计学意义(P<0.05)。结论血栓通治疗脑出血患者临床效果良好,值得广泛应用。
Objective To analyze the clinical efficacy of Xueshuantong in treating cerebral hemorrhage. Methods 87 patients with cerebral hemorrhage were randomly divided into control group (43 cases) and treatment group (44 cases). The control group was given routine treatment. The treatment group was treated with Xueshuantong injection on the basis of routine treatment, and the clinical effect was compared between the two groups. Results The volume of cerebral hematoma in the treatment group was (3.27 ± 2.33) ml, the overall change was better than that in the control group (5.39 ± 2.13) ml, the difference was statistically significant (P <0.05). The total effective rate was 88.6% Which was higher than 65.1% of the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion Xueshuantong treatment of cerebral hemorrhage in patients with good clinical results, it is widely used.